Therapeutic Drug Is Fastest Growing Segment Fueling The Growth Of West Nile Virus Market
The global West Nile virus Market is estimated to be valued at US$ 634.8 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
West Nile virus disease is caused by infection with the West Nile virus. Most
people infected with West Nile virus do not develop any symptoms. However,
about 1 in 5 people who are infected develop a fever with other symptoms such
as headache, body aches, joint pains, vomiting, diarrhea, or rash. Most people
with this milder form of West Nile fever recover completely, but fatigue and
weakness can last for weeks or months.
Market key trends:
One of the key trends in the West Nile virus market is the rise in drug
repurposing and development of therapeutics targeting various stages of viral
infection cycle. Researchers are repurposing existing drugs approved for other
viral infections and testing their effectiveness against West Nile virus. Some
of the drugs being repurposed for West Nile virus treatment include
niclosamide, which is an antiparasitic drug approved for tapeworm infections.
Segment
Analysis
The global West Nile Virus market is segmented into therapeutics and vaccines.
Among these, the therapeutics segment holds the largest market share owing to
the higher usage of treatment drugs such as alpha interferon and oxymatrine as
compared to prophylactic vaccines. The therapeutics segment is further
classified into supportive care, immunotherapy and others. Supportive care
dominated the therapeutics segment in 2022 due to rising adoption of
symptomatic treatments like fluids, rest, antipyretic medications and
acetaminophen to reduce fever caused by West Nile virus infection.
Key Takeaways
The Global
West Nile Virus Market Size is expected to witness high growth,
exhibiting CAGR of 7.6% over the
forecast period, due to increasing incidences of West Nile virus infections
globally, mainly in North America. The market size for 2023 is US$ 634.8 Mn.
Regional analysis North America dominates the global West Nile virus market and
is expected to retain its dominance over the forecast period. This is
attributed to growing West Nile virus infection cases in countries like the US.
Key players operating in the West Nile Virus market are Sanofi, Pfizer,
GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La
Roche, Novartis, Cipla, Gilead Sciences. Sanofi and Pfizer collectively account
for over 50% share of the global market due to their diversified therapy
portfolios for West Nile virus treatment.
Read More: https://www.ukwebwire.com/west-nile-virus-market-size-share-and-growth-forecast-2023-2023/
Comments
Post a Comment